Sage Therapeutics, Inc. (Nasdaq: SAGE), today reported business highlights and financial results for the second quarter ended June 30, 2025.

Biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) will be reporting earnings this Monday after market hours. Here’s what ...

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting earnings this Monday after the bell. Here’s what to ...

"This is a game changer for many who noticed a step change disease progression - some noticing improvement in function. Some ...

A groundbreaking new treatment for motor neurone disease (MND) has been approved for use in the UK, offering fresh hope after decades of despair. But campaigners warn that patients may still have to ...

The FDA has deemed Biogen's tofersen reasonably likely to produce a clinical benefit for patients.